Family · Pharmaceutical analytical standards
Brinzolamide
A carbonic anhydrase inhibitor eye drop, approved in the United States in 1998: it reduces the production of aqueous humour and so lowers the pressure inside the eye, in glaucoma and ocular hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?The enzyme it blocks, carbonic anhydrase, is one of the fastest in nature: it can carry out up to about a million reactions per second.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
